In vitro and in silico evaluation of new thieno[2,3-d]pyrimidines as anti-cancer agents and apoptosis inducers targeting VEGFR-2. - Souad A. El-Metwally; Abdelrahman A. Abuelkhir; Hazem Elkady; Mohammed S. Taghour; Ibrahim M. Ibrahim; Dalal Z. Husein; Aisha A. Alsfouk; Ahlam Sultan; Ahmed Ismail; Samy Y. Elkhawaga; Eslam B. Elkaeed; Ahmed M. Metwaly; et al. (Comput. Biol. Chem., 2023)

Design, semi-synthesis, anti-cancer assessment, docking, MD simulation, and DFT studies of novel theobromine-based derivatives as VEGFR-2 inhibitors and apoptosis inducers. - Ibrahim H. Eissa; Reda G. Yousef; Hazem Elkady; Eslam B. Elkaeed; Aisha A. Alsfouk; Dalal Z. Husein; Ibrahim M. Ibrahim; Mostafa A. Elhendawy; Murrell Godfrey; Ahmed M. Metwaly (Comput. Biol. Chem., 2023)

Anti-proliferative 2,3-dihydro-1,3,4-thiadiazoles targeting VEGFR-2: Design, synthesis, in vitro, and in silico studies. - Hazem Elkady; Walid E. Elgammal; Hazem A. Mahdy; Susi Zara; Simone Carradori; Dalal Z. Husein; Aisha A. Alsfouk; Ibrahim M. Ibrahim; Eslam B. Elkaeed; Ahmed M. Metwaly; Ibrahim H. Eissa (Comput. Biol. Chem., 2024)